{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Cieminski K"],"funding":["National Science Centre, Poland","Polish Ministry of Science and Higher Education"],"pagination":["20899"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8536703"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(1)"],"pubmed_abstract":["We tested the hypothesis that swim training reverses the impairment of Akt/FOXO3a signaling, ameliorating muscle atrophy in ALS mice. Transgenic male mice B6SJL-Tg (SOD1<sup>G93A</sup>) 1Gur/J were used as the ALS model (n = 35), with wild-type B6SJL (WT) mice as controls (n = 7). ALS mice were analyzed before ALS onset, at ALS onset, and at terminal ALS. Levels of insulin/Akt signaling pathway proteins were determined, and the body and tibialis anterior muscle mass and plasma creatine kinase. Significantly increased levels of FOXO3a in ALS groups (from about 13 to 21-fold) compared to WT mice were observed. MuRF1 levels in the ONSET untrained group (12.0 ± 1.7 AU) were significantly higher than in WT mice (1.12 ± 0.2 AU) and in the BEFORE ALS group (3.7 ± 0.9 AU). This was associated with"],"journal":["Scientific reports"],"pubmed_title":["Swim training affects Akt signaling and ameliorates loss of skeletal muscle mass in a mouse model of amyotrophic lateral sclerosis."],"pmcid":["PMC8536703"],"funding_grant_id":["DEC-2013/09/NZ7/02538","DSRiK/2019"],"pubmed_authors":["Ziolkowski W","Dzik K","Antosiewicz J","Czyrko E","Kaczor JJ","Flis DJ","Cieminski K","Halon-Golabek M","Wieckowski MR"],"additional_accession":[]},"is_claimable":false,"name":"Swim training affects Akt signaling and ameliorates loss of skeletal muscle mass in a mouse model of amyotrophic lateral sclerosis.","description":"We tested the hypothesis that swim training reverses the impairment of Akt/FOXO3a signaling, ameliorating muscle atrophy in ALS mice. Transgenic male mice B6SJL-Tg (SOD1<sup>G93A</sup>) 1Gur/J were used as the ALS model (n = 35), with wild-type B6SJL (WT) mice as controls (n = 7). ALS mice were analyzed before ALS onset, at ALS onset, and at terminal ALS. Levels of insulin/Akt signaling pathway proteins were determined, and the body and tibialis anterior muscle mass and plasma creatine kinase. Significantly increased levels of FOXO3a in ALS groups (from about 13 to 21-fold) compared to WT mice were observed. MuRF1 levels in the ONSET untrained group (12.0 ± 1.7 AU) were significantly higher than in WT mice (1.12 ± 0.2 AU) and in the BEFORE ALS group (3.7 ± 0.9 AU). This was associated with","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Oct","modification":"2025-04-20T02:06:02.542Z","creation":"2025-04-20T02:06:02.542Z"},"accession":"S-EPMC8536703","cross_references":{"pubmed":["34686697"],"doi":["10.1038/s41598-021-00319-1"]}}